Roche begins agency search for cancer drug

Roche is set to launch an agency review for its oncology drug MabThera.

Roche begins agency search for cancer drug
Roche begins agency search for cancer drug

The company has approached several UK healthcare PR specialists with a request for information, ahead of putting together a shortlist to pitch for the brief for the non-Hodgkin's lymphoma treatment.

It is understood that Amy Brice, international comms leader for the oncology arm of Roche, is overseeing the pitch process. It is unclear whether incumbent Ketchum will repitch for the account.

MabThera sits within the Roche portfolio of oncology brands alongside cancer care medication such as Avastin, Herceptin, Xeloda and Tarceva.

The Roche Group is a provider of cancer care medication including anti-cancer treatments, supportive care products and diagnostics.

It also has a wide portfolio of tumour markers as well as a range of molecular oncology tests.

The MabThera drug is harvested from Chinese hamster ovary (CHO) cells in suspension and is supplied as sterile, clear, preservative-free liquid prepared for intravenous treatment.

MabThera competes in an increasingly crowded product category. Fellow pharma companies jostling for market share include Novartis, with its lymphoma drug Lucatumumab, and several new products about to be introduced into the sector, including a tobacco-based vaccine from Swiss pharmaceutical company Bayer, which is currently undergoing human trials.

Roche was not available for comment regarding the review.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.